Cargando…

Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders

BACKGROUND: The aim of this study was to evaluate the antimicrobial resistance and genetic basis for metronidazole (Mtz) and clarithromycin (Cla) resistance in strains of Helicobacter pylori, isolated from patients with gastroduodenal disorders. PATIENTS AND METHODS: A total of 157 H. pylori isolate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashemi, Seyed Jalal, Sheikh, Ahmad Farajzadeh, Goodarzi, Hamed, Yadyad, Mohammad Jaafar, Seyedian, Seyed Saeid, Aslani, Sajad, Assarzadegan, Mohammad-Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404679/ https://www.ncbi.nlm.nih.gov/pubmed/30881059 http://dx.doi.org/10.2147/IDR.S192942

Ejemplares similares

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
por: Khademi, Farzad, et al.
Publicado: (2013)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Identification of Alloiococcus otitidis, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in Children With Otitis Media With Effusion
por: Farajzadah Sheikh, Ahmad, et al.
Publicado: (2015)

Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Sue, Soichiro, et al.
Publicado: (2018)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2018)

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis
por: Kouhsari, Ebrahim, et al.
Publicado: (2022)

Comparative Study of Helicobacter Pylori Resistance to Clarithromycin and Metronidazole and Its Association with Epidemiological Factors in A Moroccan Population
por: Essaidi, Imane, et al.
Publicado: (2022)

Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori
por: Sue, Soichiro, et al.
Publicado: (2023)

Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study
por: Liu, Ting-Wen, et al.
Publicado: (2023)

High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients
por: Shetty, Vignesh, et al.
Publicado: (2019)

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China
por: Zhang, Yanyi, et al.
Publicado: (2020)

Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection
por: Farajzadah Sheikh, Ahmad, et al.
Publicado: (2019)

Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis
por: Murata, Masaki, et al.
Publicado: (2020)

Efficacy of Clarithromycin Containing Bismuth–Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Ulcera gastroduodenal y helicobacter pylori: revisión bibliográfica.
por: Yáñez Bravo, José Juan
Publicado: (1995)

The Association Between Helicobacter Pylori and Perforated Gastroduodenal Ulcer
por: Thirupathaiah, Katavath, et al.
Publicado: (2020)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Effect of Temperature on Metronidazole Resistance in Helicobacter pylori
por: Gong, Meiliang, et al.
Publicado: (2021)

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023)

Helicobacter pylori and gastroduodenal pathology: New threats of the old friend
por: Ahmed, Niyaz, et al.
Publicado: (2005)

Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease
por: Saxena, A., et al.
Publicado: (2011)

The role of non-Helicobacter pylori bacteria in the pathogenesis of gastroduodenal diseases
por: Waskito, Langgeng Agung, et al.
Publicado: (2022)

Relationship between Helicobacter pylori virulence genes and gastroduodenal disease
por: Wattanawongdon, Wareeporn, et al.
Publicado: (2023)

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study
por: Ben Mansour, Khansa, et al.
Publicado: (2010)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains
por: Binh, Tran Thanh, et al.
Publicado: (2013)

A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori
por: Tadjrobehkar, Omid, et al.
Publicado: (2014)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

Correction: Helicobacter pylori and gastroduodenal pathology: New threats of the old friend
por: Ahmed, Niyaz, et al.
Publicado: (2008)

Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in Pakistan
por: Yakoob, Javed, et al.
Publicado: (2009)

Helicobacter pylori type 4 secretion systems as gastroduodenal disease markers
por: Phuc, Bui Hoang, et al.
Publicado: (2021)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2023)

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.
por: van der Wouden, E J, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_kfie4htlvsf3319b10oaankgcd